These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
596 related items for PubMed ID: 16676968
1. A new family of mono- and dicarboxylic ruthenium complexes [Ru(DIP)2(L2)]2+ (DIP = 4,7-diphenyl-1,10-phenanthroline): synthesis, solution behavior, and X-ray molecular structure of trans-[Ru(DIP)2(MeOH)2][OTf]2. Caspar R, Cordier C, Waern JB, Guyard-Duhayon C, Gruselle M, Le Floch P, Amouri H. Inorg Chem; 2006 May 15; 45(10):4071-8. PubMed ID: 16676968 [Abstract] [Full Text] [Related]
2. Luminescent cyclometalated Rh(III), Ir(III), and (DIP)2Ru(II) complexes with carboxylated bipyridyl ligands: synthesis, X-ray molecular structure, and photophysical properties. Waern JB, Desmarets C, Chamoreau LM, Amouri H, Barbieri A, Sabatini C, Ventura B, Barigelletti F. Inorg Chem; 2008 Apr 21; 47(8):3340-8. PubMed ID: 18341373 [Abstract] [Full Text] [Related]
3. cis-trans photoisomerization in [Ru(DIP)2(MeOH)2][OTf]2: synthesis, NMR, X-ray structure of the trans-isomer and photophysical properties. Amouri H, Waern JB, Caspar R, Barbieri A, Sabatini C, Zanelli A, Barigelletti F. Dalton Trans; 2007 Jun 07; (21):2179-86. PubMed ID: 17514339 [Abstract] [Full Text] [Related]
4. Coordination of 9-ethylguanine to the mixed-ligand compound alpha-[Ru(azpy)(bpy)Cl2] (azpy = 2-phenylazopyridine and bpy = 2,2'-bipyridine). An unprecedented ligand positional shift, correlated to the cytotoxicity of this type of [RuL2Cl2] (with L = azpy or bpy) complex. Hotze AC, van der Geer EP, Caspers SE, Kooijman H, Spek AL, Haasnoot JG, Reedijk J. Inorg Chem; 2004 Aug 09; 43(16):4935-43. PubMed ID: 15285670 [Abstract] [Full Text] [Related]
5. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action. Egger A, Arion VB, Reisner E, Cebrián-Losantos B, Shova S, Trettenhahn G, Keppler BK. Inorg Chem; 2005 Jan 10; 44(1):122-32. PubMed ID: 15627368 [Abstract] [Full Text] [Related]
6. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents. Cini R, Tamasi G, Defazio S, Corsini M, Zanello P, Messori L, Marcon G, Piccioli F, Orioli P. Inorg Chem; 2003 Dec 01; 42(24):8038-52. PubMed ID: 14632524 [Abstract] [Full Text] [Related]
7. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity. Bratsos I, Serli B, Zangrando E, Katsaros N, Alessio E. Inorg Chem; 2007 Feb 05; 46(3):975-92. PubMed ID: 17257042 [Abstract] [Full Text] [Related]
8. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity. Bratsos I, Jedner S, Bergamo A, Sava G, Gianferrara T, Zangrando E, Alessio E. J Inorg Biochem; 2008 Feb 05; 102(5-6):1120-33. PubMed ID: 18279961 [Abstract] [Full Text] [Related]
9. meso-[{Ru(phen)2}2(mu-HAT)]4+: a high-affinity DNA hairpin probe {HAT = 1,4,5,8,9,12-hexaazatriphenylene; phen = 1,10-phenanthroline}. Smith JA, Morgan JL, Turley AG, Collins JG, Keene FR. Dalton Trans; 2006 Jul 14; (26):3179-87. PubMed ID: 16802035 [Abstract] [Full Text] [Related]
10. Eilatin as a bridging ligand in ruthenium(II) complexes: synthesis, crystal structures, absorption spectra, and electrochemical properties. Gut D, Goldberg I, Kol M. Inorg Chem; 2003 Jun 02; 42(11):3483-91. PubMed ID: 12767184 [Abstract] [Full Text] [Related]
11. Synthesis and structure of ruthenium(IV) complexes featuring N-heterocyclic ligands with an N-H group as the hydrogen-bond donor: hydrogen interactions in solution and in the solid state. Díez J, Gimeno J, Merino I, Rubio E, Suárez FJ. Inorg Chem; 2011 Jun 06; 50(11):4868-81. PubMed ID: 21557560 [Abstract] [Full Text] [Related]
12. Synthesis and characterisation of ruthenium complexes containing a pendent catechol ring. O'Brien L, Duati M, Rau S, Guckian AL, Keyes TE, O'Boyle NM, Serr A, Görls H, Vos JG. Dalton Trans; 2004 Feb 21; (4):514-22. PubMed ID: 15252512 [Abstract] [Full Text] [Related]
13. Ruthenium(II) mixed-ligand complex containing 2-(4'-benzyloxy-phenyl)imidazo[4,5-f][1,10]phenanthroline: synthesis, DNA-binding and photocleavage studies. Tan LF, Wang F, Chao H, Zhou YF, Weng C. J Inorg Biochem; 2007 Apr 21; 101(4):700-8. PubMed ID: 17316812 [Abstract] [Full Text] [Related]
14. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes. Bugarcic T, Habtemariam A, Stepankova J, Heringova P, Kasparkova J, Deeth RJ, Johnstone RD, Prescimone A, Parkin A, Parsons S, Brabec V, Sadler PJ. Inorg Chem; 2008 Dec 15; 47(24):11470-86. PubMed ID: 19007206 [Abstract] [Full Text] [Related]
18. Ruthenium polypyridine complexes of tris-(2-pyridyl)-1,3,5-triazine-unusual building blocks for the synthesis of photochemical molecular devices. Schwalbe M, Karnahl M, Görls H, Chartrand D, Laverdiere F, Hanan GS, Tschierlei S, Dietzek B, Schmitt M, Popp J, Vos JG, Rau S. Dalton Trans; 2009 May 28; (20):4012-22. PubMed ID: 19440601 [Abstract] [Full Text] [Related]